Call for Human Technopole Director [CLOSED]
The Human Technopole Foundation has published an open call to appoint an outstanding scientist and visionary leader as its second Director to guide the next stages of the life sciences research Institute’s development.
Current Director Iain Mattaj will complete his four-year mandate on 31 December 2022. Having reached 70 years of age, Prof. Mattaj is unfortunately unable to continue for a second mandate and will therefore be handing over to the new Director in January 2023.
The new Director, chosen by an international search committee appointed by the Foundation’s Supervisory Board, will take over from the very successful start-up phase led by Prof. Mattaj during which HT built up core lab facilities, recruited over 20 world-class research group leaders and attracted nearly 8.5 million euros in extramural funding.
The new Director will ensure full continuity by further expanding on these successes with the necessary scientific leadership and guidance.
Share:
You could also like:
-
From RNA to proteins: AIRC supports Human Technopole’s new approaches to cancer research
Lorenzo Calviello and his group of the Human Technopole’s Research Centres for Genomics and Computational Biology have been awarded a five-year My First AIRC Grant by Fondazione AIRC per la Ricerca sul Cancro. The grant provides over €99,000 for 2026, for a total of €500,000, to support a project aimed at identifying cancer-specific proteins that could serve as new immunotherapy targets in colorectal cancer.
-
How sortilin senses thyroglobulin along its pathway to thyroid hormone release
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
-
AI4Life: A European Success for Artificial Intelligence in the Life Sciences
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
-
Human Technopole awarded FIS grant for precision immunotherapy research
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
-
Highlights from the 2nd Conference “Future Trends in Translational Medicine”
Turning scientific discoveries into real-world therapies was the focus of the second international conference “Future Trends in Translational Medicine – From Molecules to Therapies,” held at the Complesso Universitario di San Giovanni a Teduccio in Naples on 30 -31 October 2025.